Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol versus fenoterol + ipratropium in children with acute asthma-related bronchial obstruction
2015-004464-11Phase 4
- Sponsor
- Novartis
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma and acute airway obstruction comparing Formoterol arm with Fenoterol + ipratropium bromide arm (2 arms). Primary endpoint: Mean change in maximum expiratory flow from baseline to final evaluation.
02
Drugs
formoterolfenoterol + ipratropium
03
Conditions
asthmaacute airway obstruction
Beyond the preview
Go deeper on 2015-004464-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004464-11.